Citigroup Inc Quanterix Corp Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Quanterix Corp stock. As of the latest transaction made, Citigroup Inc holds 14,595 shares of QTRX stock, worth $183,313. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,595

Previous 12,713 14.8%

Holding current value

$183,313

Previous $299,000 35.79%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$12.26 - $23.78 $23,073 - $44,753	1,882 Added 14.8%	14,595 $192,000
Q1 2024 May 10, 2024	BUY	$21.9 - $28.28 $168,651 - $217,784	7,701 Added 153.65%	12,713 $299,000
Q4 2023 Feb 09, 2024	BUY	$19.54 - $28.66 $96,293 - $141,236	4,928 Added 5866.67%	5,012 $137,000
Q3 2023 Nov 09, 2023	SELL	$21.15 - $27.96 $239,121 - $316,115	-11,306 Reduced 99.26%	84 $2,000
Q2 2023 Aug 10, 2023	BUY	$11.16 - $23.65 $117,246 - $248,466	10,506 Added 1188.46%	11,390 $256,000
Q1 2023 May 11, 2023	SELL	$10.12 - $14.91 $2,530 - $3,727	-250 Reduced 22.05%	884 $9,000
Q4 2022 Feb 09, 2023	SELL	$8.75 - $14.02 $2,528 - $4,051	-289 Reduced 20.31%	1,134 $15,000
Q3 2022 Nov 10, 2022	SELL	$7.46 - $19.28 $17,202 - $44,459	-2,306 Reduced 61.84%	1,423 $15,000
Q2 2022 Aug 10, 2022	BUY	$15.06 - $30.65 $24,653 - $50,174	1,637 Added 78.25%	3,729 $61,000
Q1 2022 May 12, 2022	SELL	$23.26 - $42.41 $148,282 - $270,363	-6,375 Reduced 75.29%	2,092 $62,000
Q4 2021 Feb 10, 2022	BUY	$37.54 - $57.51 $166,001 - $254,309	4,422 Added 109.32%	8,467 $359,000
Q3 2021 Nov 10, 2021	BUY	$45.91 - $59.67 $185,705 - $241,365	4,045 New	4,045 $201,000

Others Institutions Holding QTRX

# of Institutions

158

Shares Held

32.1M

Call Options Held

39K

Put Options Held

5.5K

View Full List

About Quanterix Corp

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $465M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

More about QTRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account